XML 184 R107.htm IDEA: XBRL DOCUMENT v3.26.1
Discontinued operations - Staff costs (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disclosure of analysis of single amount of discontinued operations [line items]      
Salaries, wages and other benefits $ 21,254 $ 18,999 $ 19,167
Contributions to defined contribution retirement plan 237 135 122
Equity-settled share-based payment expenses 4,286 5,356 10,142
Total staff costs 25,777 24,490 29,431
Direct costs      
Disclosure of analysis of single amount of discontinued operations [line items]      
Total staff costs 2,281 110 928
Administrative and other operating expenses      
Disclosure of analysis of single amount of discontinued operations [line items]      
Total staff costs 17,039 14,929 18,520
Discontinued operations      
Disclosure of analysis of single amount of discontinued operations [line items]      
Salaries, wages and other benefits 5,647 7,997 17,700
Contributions to defined contribution retirement plan 441 565 597
Equity-settled share-based payment expenses 1,254 2,004 354
Total staff costs 7,342 10,566 18,651
Discontinued operations | Direct costs      
Disclosure of analysis of single amount of discontinued operations [line items]      
Total staff costs 365 492 3,128
Discontinued operations | Selling and marketing expenses      
Disclosure of analysis of single amount of discontinued operations [line items]      
Total staff costs 2,003 2,726 2,536
Discontinued operations | Research and development expenses      
Disclosure of analysis of single amount of discontinued operations [line items]      
Total staff costs 731 1,142 1,598
Discontinued operations | Administrative and other operating expenses      
Disclosure of analysis of single amount of discontinued operations [line items]      
Total staff costs 4,243 6,206 11,389
Discontinued operations | Prevention and diagnostics - COVID-19 related and EMEA operations      
Disclosure of analysis of single amount of discontinued operations [line items]      
Salaries, wages and other benefits 0 0 9,122
Contributions to defined contribution retirement plan 0 0 0
Equity-settled share-based payment expenses 0 0 0
Total staff costs 0 0 9,122
Discontinued operations | Prevention and diagnostics - COVID-19 related and EMEA operations | Direct costs      
Disclosure of analysis of single amount of discontinued operations [line items]      
Total staff costs 0 0 2,058
Discontinued operations | Prevention and diagnostics - COVID-19 related and EMEA operations | Selling and marketing expenses      
Disclosure of analysis of single amount of discontinued operations [line items]      
Total staff costs 0 0 0
Discontinued operations | Prevention and diagnostics - COVID-19 related and EMEA operations | Research and development expenses      
Disclosure of analysis of single amount of discontinued operations [line items]      
Total staff costs 0 0 0
Discontinued operations | Prevention and diagnostics - COVID-19 related and EMEA operations | Administrative and other operating expenses      
Disclosure of analysis of single amount of discontinued operations [line items]      
Total staff costs 0 0 7,064
Discontinued operations | ACT genomics      
Disclosure of analysis of single amount of discontinued operations [line items]      
Salaries, wages and other benefits 5,647 7,997 8,578
Contributions to defined contribution retirement plan 441 565 597
Equity-settled share-based payment expenses 1,254 2,004 354
Total staff costs 7,342 10,566 9,529
Discontinued operations | ACT genomics | Direct costs      
Disclosure of analysis of single amount of discontinued operations [line items]      
Total staff costs 365 492 1,070
Discontinued operations | ACT genomics | Selling and marketing expenses      
Disclosure of analysis of single amount of discontinued operations [line items]      
Total staff costs 2,003 2,726 2,536
Discontinued operations | ACT genomics | Research and development expenses      
Disclosure of analysis of single amount of discontinued operations [line items]      
Total staff costs 731 1,142 1,598
Discontinued operations | ACT genomics | Administrative and other operating expenses      
Disclosure of analysis of single amount of discontinued operations [line items]      
Total staff costs $ 4,243 $ 6,206 $ 4,325